GABA(B) receptors decrease the release of GABA from the striatal terminals within the pars reticulata of the substantia nigra by opposing the increase in the release caused by dopamine D₁ receptors. The dopamine D₁ receptors also increase the release of glutamate from subthalamic terminals in the pars reticulata. Because GABA(B) receptors decrease the glutamate release from these terminals, we have explored if the effect of GABA(B) receptors also opposed the effect of the dopamine D₁ receptors. The effect of baclofen, a selective GABA(B)-receptor agonist, was tested on the release of [³H]glutamate caused by highly (40 mM) concentrated K(+) solutions in slices of the pars reticulata. Baclofen decreased (the concentration causing 50% inhibition, IC₅₀, was 8.15 μM) the increase in the release of the [³H]glutamate caused by the dopamine D₁ receptors and it also decreased (IC₅₀ was 0.51 μM) this release in the absence of the activation of the dopamine D₁ receptors. The GABA(B) receptors appear then to inhibit glutamate release in two ways; one dependent on the activation of the dopamine D₁ receptors and the other independent of such activation. The protein kinase A-inhibitor H89 blocked the increase in the release of the [³H]glutamate caused by the dopamine D₁ receptors, though it did not block the dopamine D₁ receptor-independent baclofen inhibition of the release. This finding indicates that this inhibition was not via the protein kinase A signal-transduction pathway. N-ethylmaleimide, an alkylating agent that inactivates pertussis toxin-sensitive Gi proteins, eliminated both the dopamine D₁ receptor-dependent and -independent baclofen inhibition, showing that both were mediated by these proteins. The injection of baclofen into the pars reticulata of unanesthetized rats caused contralateral rotation, suggesting a reduced glutamate release from the subthalamic terminals, thereby stopping the inhibition of the premotor thalamic nuclei, causing locomotion. Our data suggest that GABA(B) receptors restrain the excitatory input from the subthalamic nucleus and stimulate motor behavior.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejphar.2010.09.024 | DOI Listing |
MRS Adv
November 2022
Department of Chemical & Biomolecular Engineering, Case Western Reserve University, Cleveland, OH, USA.
Nanodiamond (ND) with nitrogen vacancy (NV) color centers has emerged as an important material for quantum sensing and imaging. Fluorescent, carboxylated ND (140 nm) is investigated for the detection of dopamine (DA), caffeine (CA), and ascorbic acid (AA). Over a 200 nM range, DA and CA quenched the ND fluorescence by 7.
View Article and Find Full Text PDFLangmuir
August 2022
School of Mechanical Engineering, Jiangnan University, Wuxi, Jiangsu 214122, China.
Existing medical materials (such as silicone rubber, glass slides, etc.) fail to meet the functional requirements of biosensing, cell culture, and drug delivery due to their poor wettability. The preparation of polyelectrolyte coatings with excellent wettability and protein adsorption helps broaden the application of medical materials.
View Article and Find Full Text PDFJ Nanobiotechnology
August 2020
School of Life Science and Chemistry, Hunan University of Technology, Zhuzhou, 412007, China.
A method with high sensitivity, good accuracy and fast response is of ever increasing importance for the simultaneous detection of AA, DA and UA. In this paper, a simple and sensitive electrochemical sensor, which based on the polyvinylpyrrolidone (PVP)-graphene composite film modified glassy carbon electrode (PVP-GR/GCE), was presented for detecting ascorbic acid (AA), dopamine (DA) and uric acid (UA) simultaneously. The PVP-GR/GCE has excellent electrocatalytic activity for the oxidation of AA, DA and UA.
View Article and Find Full Text PDFTalanta
September 2012
College of Chemistry and Chemical Engineering, Key Lab of Bioelectrochemistry and Environmental Analysis of Gansu Province, Northwest Normal University, Lanzhou 730070, PR China.
A promising electrochemical sensor for simultaneous determination of dopamine (DA), uric acid (UA) and ascorbic acid (AA) was fabricated based on the stacked graphene platelet nanofibers (SGNF)/ionic liquid (IL)/chitosan (CS) modified electrode. The SGNF/IL/CS modified electrode possessed excellent electrocatalytic activity towards the oxidation of DA, UA and AA with obvious reduction of over-potential and increased peak current, and the separations of oxidation peak potentials of DA-UA, DA-AA, and UA-AA were of 151, 213 and 364 mV, respectively. Under the optimum conditions, the linear range for the detection of DA, UA and AA were 0.
View Article and Find Full Text PDFColloids Surf B Biointerfaces
December 2011
Research Centre for Environmental Technology and Sustainable Development, Hanoi University of Science, 334 Nguyen Trai Road, Ha Noi, Viet Nam.
A voltammetric method based on a combination of incorporated Nafion, single-walled carbon nanotubes and poly(3-methylthiophene) film-modified glassy carbon electrode (NF/SWCNT/PMT/GCE) has been successfully developed for selective determination of dopamine (DA) in the ternary mixture of dopamine, ascorbic acid (AA) and uric acid (UA) in 0.1M phosphate buffer solution (PBS) pH 4. It was shown that to detect DA from binary DA-AA mixture, the use of NF/PMT/GCE was sufficient, but to detect DA from ternary DA-AA-UA mixture NF/SWCNT/PMT/GCE was required.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!